Discovery of amide-functionalized benzimidazolium salts as potent α-glucosidase inhibitors
α-Glucosidase inhibitors (AGIs) are used as medicines for the treatment of diabetes mellitus. The α-Glucosidase enzyme is present in the small intestine and is responsible for the breakdown of carbohydrates into sugars. The process results in an increase in blood sugar levels. AGIs slow down the dig...
出版年: | Molecules |
---|---|
第一著者: | 2-s2.0-85112329694 |
フォーマット: | 論文 |
言語: | English |
出版事項: |
MDPI AG
2021
|
オンライン・アクセス: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112329694&doi=10.3390%2fmolecules26164760&partnerID=40&md5=bc2b6a585ad05ed6048fce3d82640811 |
類似資料
-
Development of benzimidazolium salt-based cubosome hydrogel for topical treatment of burns
著者:: 2-s2.0-85217012735
出版事項: (2025) -
Synthesis of Indole Based Sulfonamide Derivatives as potent inhibitors of α-glucosidase and α-amylase in management of type-II diabetes
著者:: 2-s2.0-85185155619
出版事項: (2024) -
Novel quinoline derivatives as potent in vitro α-glucosidase inhibitors: In silico studies and SAR predictions
著者:: 2-s2.0-84943771420
出版事項: (2015) -
Evaluation of 2-indolcarbohydrazones as potent α-glucosidase inhibitors, in silico studies and DFT based stereochemical predictions
著者:: 2-s2.0-84942794211
出版事項: (2015) -
Synthesis and biological evaluation of novel coumarin derivatives bearing sulfonamide moiety as potent α-glucosidase inhibitors
著者:: Alsukor A.; Inayatsyah N.A.; Ridhwan M.J.M.; Kasim N.; Imran S.
出版事項: (2025)